hotspot -WSS

hotspot

author：leisure time 2025-10-01 23:01:06 - browse：4

The US Supreme Court silhouetted -- Abortion coverage from STAT — STEFANI REYNOLDS/AFP via Getty Images

WASHINGTON — The Supreme Court on Monday wrestled with a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over the toll of opioids.

The justices seemed by turns relucant to break up an exhaustively negotiated agreement, but also leery of somehow rewarding the Sacklers.

The agreement hammered out with state and local governments and victims would provide billions of dollars to combat the opioid epidemic. The Sacklers would contribute up to $6 billion and give up ownership of the company, but retain billions more. The company would emerge from bankruptcy as a different entity, with its profits used for treatment and prevention.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

WSS

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

Carbon Health diabetes program, a test of data

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

Humana cuts profit projections as Medicare Advantage costs soar

leisure time

hotspot

entertainment

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Prior authorization will have to move faster under new Biden rule

Activists slam private health insurers over coverage restrictions

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

Peter Hotez and the public health issue of online harassment

How digital therapeutics firms are pivoting after Pear's bankruptcy

Dobbs anniversary: the lost opportunity of abortion as health care

Test for long Covid? Researchers find new clue in blood samples

23andMe had bad news about my health. I wish a person had delivered it

EU regulator recommends expanding Mounjaro approval to obesity

Wikipedia

Publishing genetic code of viruses could cause disaster

AI generated plenty of interest at JPM but not a lot of trust

First transplant of an entire human eye performed

Medicare’s new pay boost for primary care is angering specialists

My yearlong odyssey to get my son’s ADHD medication covered

Today's health inequities arise from racist U.S. history, say experts

leisure time

hotspot

hotspot

knowledge